AU2000260652B2 - Extended type 1 chain glycosphingolipids as tumor-associated antigens - Google Patents

Extended type 1 chain glycosphingolipids as tumor-associated antigens Download PDF

Info

Publication number
AU2000260652B2
AU2000260652B2 AU2000260652A AU2000260652A AU2000260652B2 AU 2000260652 B2 AU2000260652 B2 AU 2000260652B2 AU 2000260652 A AU2000260652 A AU 2000260652A AU 2000260652 A AU2000260652 A AU 2000260652A AU 2000260652 B2 AU2000260652 B2 AU 2000260652B2
Authority
AU
Australia
Prior art keywords
neuaca2
fucal
isolated compound
4glc
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU2000260652A
Other languages
English (en)
Other versions
AU2000260652A1 (en
Inventor
Sen-Itiroh Hakomori
Steven Levery
Mark Stroud
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomembrane Institute
Original Assignee
Biomembrane Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomembrane Institute filed Critical Biomembrane Institute
Publication of AU2000260652A1 publication Critical patent/AU2000260652A1/en
Application granted granted Critical
Publication of AU2000260652B2 publication Critical patent/AU2000260652B2/en
Anticipated expiration legal-status Critical
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02Acyclic radicals, not substituted by cyclic structures
    • C07H15/04Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials Engineering (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Peptides Or Proteins (AREA)
AU2000260652A 2000-07-03 2000-07-03 Extended type 1 chain glycosphingolipids as tumor-associated antigens Expired AU2000260652B2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/018219 WO2002002127A1 (en) 2000-07-03 2000-07-03 Extended type 1 chain glycosphingolipids as tumor-associated antigens

Publications (2)

Publication Number Publication Date
AU2000260652A1 AU2000260652A1 (en) 2002-04-11
AU2000260652B2 true AU2000260652B2 (en) 2005-10-27

Family

ID=21741553

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2000260652A Expired AU2000260652B2 (en) 2000-07-03 2000-07-03 Extended type 1 chain glycosphingolipids as tumor-associated antigens
AU6065200A Pending AU6065200A (en) 2000-07-03 2000-07-03 Extended type 1 chain glycosphingolipids as tumor-associated antigens

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU6065200A Pending AU6065200A (en) 2000-07-03 2000-07-03 Extended type 1 chain glycosphingolipids as tumor-associated antigens

Country Status (6)

Country Link
EP (1) EP1307207A4 (enExample)
JP (1) JP2004502025A (enExample)
KR (1) KR100666238B1 (enExample)
CN (1) CN1291723C (enExample)
AU (2) AU2000260652B2 (enExample)
WO (1) WO2002002127A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5331293B2 (ja) * 2006-04-28 2013-10-30 公益財団法人野口研究所 多様性を表現するオリゴ糖またはその誘導体
KR101432474B1 (ko) * 2008-09-07 2014-08-21 글라이코넥스 인코포레이티드 항-연장된 ⅰ형 글라이코스핑고지질 항체, 이의 유도체 및 용도
CN104655859B (zh) * 2013-11-21 2017-10-03 苏州中赢医疗科技有限公司 乳腺癌的诊断标志物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6083929A (en) * 1991-05-06 2000-07-04 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens
WO1992019634A1 (en) * 1991-05-06 1992-11-12 The Biomembrane Institute Extended type 1 chain glycosphingolipids as tumor-associated antigens

Also Published As

Publication number Publication date
JP2004502025A (ja) 2004-01-22
CN1291723C (zh) 2006-12-27
EP1307207A1 (en) 2003-05-07
CN1460022A (zh) 2003-12-03
KR20030068120A (ko) 2003-08-19
WO2002002127A1 (en) 2002-01-10
EP1307207A4 (en) 2005-12-14
AU6065200A (en) 2002-01-14
KR100666238B1 (ko) 2007-01-09

Similar Documents

Publication Publication Date Title
Le Pendu et al. ABH and Lewis histo‐blood group antigens in cancer
Stroud et al. Extended type 1 chain glycosphingolipids: dimeric Lea (III4V4Fuc2Lc6) as human tumor-associated antigen
Satoh et al. Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells
US20030133937A1 (en) Methods and compositions for the inhibition of cancer metastasis mediated by endothelial adhesion molecules
Casadesús et al. A shift from N-glycolyl-to N-acetyl-sialic acid in the GM3 ganglioside impairs tumor development in mouse lymphocytic leukemia cells
Goletz et al. Thomsen-Friedenreich antigen: the “hidden” tumor antigen
Mårtensson et al. A carbohydrate epitope associated with human squamous lung cancer
US6083929A (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens
EP2113515A2 (en) GalNAc specific binding molecules and uses thereof
AU2000260652B2 (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens
Masson et al. Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status
Ito et al. Specificity and immunobiological properties of monoclonal antibody IMH2, established after immunization with Leb/Lea glycosphingolipid, a novel extended type 1 chain antigen
JPH07504222A (ja) 化学的に規定されるオリゴ糖,該オリゴ糖の誘導体,擬態物及び該オリゴ糖に対する抗体による細胞接着の抑制
AU2000260652A1 (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens
EP1169044B1 (en) Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
Medina et al. Human colon adenocarcinomas express a MUC1-associated novel carbohydrate epitope on core mucin glycans defined by a monoclonal antibody (A10) raised against murine Ehrlich tumor cells
Garratty Do blood groups have a biological role
AU659808B2 (en) Inhibition of metastasis potential and invasiveness by oligosaccharides or oligosaccharide antigens or antibodies
WO1992019634A1 (en) Extended type 1 chain glycosphingolipids as tumor-associated antigens
Hiraiwa et al. Monoclonal antibodies directed to a disulfated glycosphingolipid, SB1a (GgOse4Cer-II3IV3-bis-sulfate), associated with human hepatocellular carcinoma
FUKUSHIMA Expression of Lewisx, sialylated Lewisx, Lewisa, and sialylated Lewisa antigens in human lung carcinoma
JP2007191490A (ja) 腫瘍関連抗原としての拡張i型スフィンゴ糖脂質鎖
Okada et al. Hepatocellular expression of a novel glycoprotein with sialylated difucosyl Lex activity in the active inflammatory lesions of chronic liver disease
Hanisch et al. Monoclonal antibody FW6 defines an epitope on α3/4-monofucosylated polylactosaminoglycans expressed by fetal and colon carcinoma-associated mucins
Laferté et al. Monoclonal antibody recognizing a determinant on type 2 chain blood group A and B oligosaccharides detects oncodevelopmental changes in azoxymethane‐induced rat colon tumors and human colon cancer cell lines

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired